Fundraising Fox
Fore Biotherapeutics
Philadelphia, US · 55 employees on LinkedIn · 11 known investors
Find your way into Fore Biotherapeutics
Sign up to see every warm intro you have to Fore Biotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fore Biotherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.
Investors · 11
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
How we know: HBM Partners's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: LG Technology Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Novartis Venture Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Pontifax Venture Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: SR One Capital Management's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Windham Capital Partners's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$67.4M disclosed across 1 of 2 rounds · 2026
- $67.4MSeries D-2 ExtensionJul 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 1
Companies working in the same space as Fore Biotherapeutics.
In the news
Frequently asked questions
- What does Fore Biotherapeutics do?
- Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.
- Who are Fore Biotherapeutics's investors?
- Fore Biotherapeutics's investors include HBM Healthcare Investments, HBM Partners, LG Technology Ventures, Novartis Venture Fund, OrbiMed, Pontifax Venture Capital, SR One Capital Management, Wellington Management and 3 more.
- How much funding has Fore Biotherapeutics raised?
- Fore Biotherapeutics has disclosed $67.4M raised across 1 of its 2 known rounds.
- Where is Fore Biotherapeutics headquartered?
- Fore Biotherapeutics is headquartered in Philadelphia, US.